341 related articles for article (PubMed ID: 18497249)
1. [Type 2 diabetes. Routine ACE inhibitors?].
Hönl SB
Med Monatsschr Pharm; 2008 Apr; 31(4):149-50. PubMed ID: 18497249
[No Abstract] [Full Text] [Related]
2. Hypertension arm of ADVANCE defines extent of renal protection using perindopril/indapamide in type 2 diabetics.
Cardiovasc J Afr; 2008; 19(4):226. PubMed ID: 18776973
[No Abstract] [Full Text] [Related]
3. [Need of tight blood pressure control in type 2 diabetes. The intervention study ADVANCE gives clear information].
Nilsson PM
Lakartidningen; 2007 Oct 17-23; 104(42):3028-9. PubMed ID: 17985709
[No Abstract] [Full Text] [Related]
4. Efficacy and safety of fixed combination of perindopril and indapamide in type 2 diabetes: results from ADVANCE in context of available evidence.
Chalmers J; Joshi R; Kengne AP; Ninomiya T; Bi Y; Bompoint S; Billot L; Patel A;
J Hypertens Suppl; 2008 Sep; 26(3):S21-7. PubMed ID: 19363849
[TBL] [Abstract][Full Text] [Related]
5. The ADVANCE trial: clarifying the role of perindopril/indapamide fixed-dose combination in the reduction of cardiovascular and renal events in patients with diabetes mellitus.
Waeber B; de la Sierra A; Ruilope LM
Am J Cardiovasc Drugs; 2009; 9(5):283-91. PubMed ID: 19791837
[TBL] [Abstract][Full Text] [Related]
6. Perindopril/indapamide combination in the first-line treatment of hypertension and end-organ protection.
Gosse P
Expert Rev Cardiovasc Ther; 2006 May; 4(3):319-33. PubMed ID: 16716093
[TBL] [Abstract][Full Text] [Related]
7. [ADVANCE: a morbidity mortality study of diabetes and hypertension].
Heim A; Feihl F; Waeber B
Rev Med Suisse; 2008 Jan; 4(139):28, 30, 32-3. PubMed ID: 18251212
[TBL] [Abstract][Full Text] [Related]
8. [Antihypertensive therapy in diabetic patients. What do the new data mean for the practice?].
Holzgreve H
MMW Fortschr Med; 2007 Sep; 149(38):19. PubMed ID: 18018408
[No Abstract] [Full Text] [Related]
9. [ADVANCE study: objectives, design and current status].
Chalmers J
Drugs; 2003; 63 Spec No 1():39-44. PubMed ID: 12708881
[TBL] [Abstract][Full Text] [Related]
10. Blood pressure and stroke; the PROGRESS trial.
He FJ; MacGregor GA
J Renin Angiotensin Aldosterone Syst; 2001 Sep; 2(3):153-5. PubMed ID: 11881116
[No Abstract] [Full Text] [Related]
11. Implications of the ADVANCE study for clinical practice.
Zannad F
J Hypertens Suppl; 2008 Sep; 26(3):S29-32. PubMed ID: 19363850
[TBL] [Abstract][Full Text] [Related]
12. [Type 2 diabetes: blood pressure lowering to 135/75 mmHg reduces mortality].
Einecke D
MMW Fortschr Med; 2007 Sep; 149(38):18. PubMed ID: 18018407
[No Abstract] [Full Text] [Related]
13. The PROGRESS trial three years later: time for more action, less distraction.
Macmahon S; Neal B; Rodgers A; Chalmers J
BMJ; 2004 Oct; 329(7472):970-1. PubMed ID: 15499117
[No Abstract] [Full Text] [Related]
14. New Premier study suggest Preterax as a first-line antihypertensive.
Cardiovasc J S Afr; 2004; 15(1):40-1. PubMed ID: 15095752
[No Abstract] [Full Text] [Related]
15. [Hypotensive and metabolic effect of indapamide and perindopril in patients with type 2 diabetes and arterial hypertensia].
Askerov MM
Georgian Med News; 2009 Apr; (169):44-8. PubMed ID: 19430043
[TBL] [Abstract][Full Text] [Related]
16. Vascular and renal benefits are additive using intensive blood pressure control and incremental glucose control in type 2 diabetic patients.
Cardiovasc J Afr; 2008; 19(5):284-6. PubMed ID: 18997995
[No Abstract] [Full Text] [Related]
17. Perindopril + indapamide: new preparation. Simple trick.
Prescrire Int; 1999 Dec; 8(44):172-5. PubMed ID: 11503814
[TBL] [Abstract][Full Text] [Related]
18. Very-low-dose combination of perindopril and indapamide as a novel strategy in first-line management of hypertension.
de Leeuw PW; ;
J Hypertens Suppl; 2001 Sep; 19(3):S41-5. PubMed ID: 11713850
[TBL] [Abstract][Full Text] [Related]
19. Combination of the angiotensin-converting enzyme inhibitor perindopril and the diuretic indapamide activate postnatal vasculogenesis in spontaneously hypertensive rats.
You D; Cochain C; Loinard C; Vilar J; Mees B; Duriez M; Lévy BI; Silvestre JS
J Pharmacol Exp Ther; 2008 Jun; 325(3):766-73. PubMed ID: 18309090
[TBL] [Abstract][Full Text] [Related]
20. Combination BP therapy cuts second stroke risk in half.
Geriatrics; 2001 Aug; 56(8):14, 16. PubMed ID: 11505852
[No Abstract] [Full Text] [Related]
[Next] [New Search]
